Impact of EML4-ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients with Non-small Cell Lung Cancer
THORACIC CANCER（2025）
Key words
EML4-ALK,NSCLC,TKI,TP53
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined